Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-018-4996-3.pdf
Reference109 articles.
1. World Health Organization. WHO | breast cancer: prevention and control. http://www.who.int/cancer/detection/breastcancer/en/ . Accessed 26 Nov 2017
2. Siegel RL, Miller KD, Jemal A. Cancer statistics (2018) CA Cancer J Clin 2018 68(1):7–30. https://doi.org/10.3322/caac.21442
3. Moscetti L, Agnese Fabbri M, Sperduti I et al (2015) Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment? Tumori 101(5):469. https://doi.org/10.5301/tj.5000376
4. Saggar V, Wu S, Dickler MN, Lacouture ME (2013) Alopecia with endocrine therapies in patients with cancer. Oncologist 18(10):1126–1134. https://doi.org/10.1634/theoncologist.2013-0193 . Epub 13 Sep 2013
5. Smith IE, Dowsett M (2003) Aromatase inhibitors in breast cancer. N Engl J Med 348(24):2431–2442. https://doi.org/10.1056/NEJMra023246 . Accessed 6 April 2018
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients;Supportive Care in Cancer;2023-11-22
2. Medical Treatment for Androgenetic Alopecia;Facial Plastic Surgery;2023-10-23
3. Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial;Journal of Cosmetic Dermatology;2023-09-10
4. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery;Genes & Diseases;2023-07
5. Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis;Current Pharmaceutical Design;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3